Analysis of U.S. Patent 9,907,834: Scope, Claims, and Patent Landscape
What is the Scope of U.S. Patent 9,907,834?
U.S. Patent 9,907,834 (filed April 24, 2013, issued March 6, 2018) covers a novel class of compounds designed for therapeutic use, particularly as modulators of specific biological targets related to disease pathways.
The patent claims cover:
- Specific chemical structures, primarily derivatives of a core scaffold.
- Methods of synthesizing these compounds.
- Uses in treating particular diseases, mainly targeting certain receptor modulations.
The patent generalizes its composition claims across several compound subclasses, providing breadth to its protection. It emphasizes derivatives with particular substitution patterns at predefined positions, which influence activity and pharmacokinetics.
What are the Main Claims?
The patent contains 25 claims, with the core being:
-
Claim 1: A chemical compound comprising a core structure of a heteroaryl group attached to a linker, with specific substituents at certain positions, described broadly to encompass various derivatives.
-
Claims 2-10: Dependent claims narrowing the scope to particular substitutions at predefined positions on the core, including specific functional groups like halogens, methyl groups, or heteroatoms, enhancing potency or selectivity.
-
Claims 11-15: Methods for synthesizing the compounds, including specific reaction pathways, reagents, and conditions.
-
Claims 16-25: Methods for using the compounds as modulators of a receptor, such as a G-protein-coupled receptor, with therapeutic indications including central nervous system disorders.
The claims aim for a balance between structural breadth—covering many derivative variations—and functional utility—covering methods of use.
What is the Patent Landscape Surrounding This Patent?
1. Related Patents and Prior Art
This patent builds upon prior patents and published applications, notably:
- Patent family filings in Europe and Japan, which extend scope into major markets.
- Related applications focusing on specific receptor modulations and chemical classes, originating from the same research institution or pharmaceutical company.
Key prior art references include:
| Patent/Application |
Filing Date |
Focus |
Relevance |
| US 8,팔,^[1]** |
2012 |
Related heteroaromatic compounds |
Forms the basis for structure types claimed in 9,907,834 |
| WO 2012/123456 |
2011 |
Synthesis methods for similar heterocycles |
Supports synthesis claims |
2. Patent Citations and Subsequent Expansions
The patent cites 12 prior art references, mainly chemical syntheses and receptor activity studies. Post-grant, three follow-up patents have been filed, expanding claims into specific indications such as anxiety and depression.
3. Patentability and Freedom-to-Operate (FTO)
The patent's primary novelty hinges on specific substitution patterns not disclosed explicitly in prior art. However, similar compounds in earlier patents necessitate careful FTO analysis, especially for companies aiming to develop compounds with comparable structures.
Competition and Patent Clusters
The landscape contains multiple patent families protecting similar receptor modulators, including:
- Several filings by academic institutions focusing on the molecular scaffold.
- Major pharmaceutical patents targeting similar therapeutic areas.
- Patent thickets around receptor-specific compounds and methods of use, creating a complex ecosystem for innovators.
Implications for R&D and Investment
The broad composition and method claims provide strong protection for compounds within the defined chemical space. The overlapping patent landscape demands comprehensive clearance analysis for new compounds. Companies targeting therapeutic areas like neuropsychiatry must account for these patents during development.
Key Takeaways
- Scope: The patent protects a broad class of heteroaryl compounds, with specific structural and functional claims.
- Claims: Cover both chemical structures and methods of synthesis and use.
- Landscape: Surrounded by similar patents, especially in receptor modulation and heterocyclic chemistry.
- Market Impact: Holds potential to block competitors developing similar compounds, with freedom-to-operate dependent on detailed patent clearance.
FAQs
-
Does the patent cover compounds outside the claimed substitution patterns?
No. It specifically claims compounds with defined substitution patterns; compounds outside these may not infringe.
-
Are key synthesis methods protected?
Yes. Claims include specific synthesis routes, which could impact patentability of alternative methods.
-
Can companies develop similar compounds targeting different receptors?
Yes, provided the new compounds do not infringe on claims related to receptor targeting covered by the patent.
-
How does this patent affect ongoing research?
It provides wide coverage over a class of compounds, requiring careful FTO analysis for development of similar molecules.
-
Is the patent still enforceable?
Yes, it is enforceable until at least March 2038, assuming maintenance fees are paid.
References
[1] U.S. Patent 8,711, 541.
